SINOVAC Named BogotáBio Exclusive Partner, Fueling New Vaccine Advances in Colombia
BogotáBio, implementing an innovative collaboration model between the public and private sectors in the pharmaceutical sector in Bogota,…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
06 Jun 23
BogotáBio, implementing an innovative collaboration model between the public and private sectors in the pharmaceutical sector in Bogota,…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
06 Jun 23
New EVOQ DART-TQ+ system for chromatography-free triple-quadrupole mass spectrometry for point-of-need (PoN) routine analysis. Launch of impact™ II…
05 Jun 23
The Phase 3 study, which enrolled 682 patients with early-stage (IB, II and IIIA) epidermal growth factor receptor-mutated…
05 Jun 23
The late-stage trial evaluated patients with Stage II and III hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-)…
05 Jun 23
The health company uses it to create dissolvable oral strips out of its distinctive formulations of necessary nutrition,…
05 Jun 23
Vorasidenib met its primary endpoint of progression free survival per the blinded independent review committee and achieved its…
05 Jun 23
Leveraging Selvita's expertise in protein degradation and neuroscience, Professor Tofaris and his team have collaborated with Selvita to…
05 Jun 23
Customized high-protein, high-fiber, low-calorie smoothie mix to deliver every vitamin, mineral and antioxidant your body needs
05 Jun 23
Starpharma is progressing discussions with potential commercial partners in Malaysia, with the view of distributing VIRALEZE through local…
02 Jun 23
The license agreement provides Bayer with exclusive rights to develop and commercialise Cedilla’s CyclinE1/CDK2 inhibitors that are currently…